Chief Regulatory Officer of Flexion Therapeutics Inc (NASDAQ:FLXN), Wentworth Kerry, sells 6,829 shares worth $76,007

According to Flexion Therapeutics Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 07 05:56 PM, company Chief Regulatory Officer, Wentworth Kerry disclosed selling 6,829 shares at a cost of $11.13. At the time of this transaction (Jan 05), this trade was worth $76,007 in total. As of Jan 05, Wentworth Kerry now owns 113,767 shares in total worth about $1,423,225.17.

For the last few recent trades made by Flexion Therapeutics Inc (NASDAQ:FLXN) Chief Regulatory Officer, Wentworth Kerry, we have the following information:

  1. SEC Form 4 filing: Jan 03: Sold 622 shares at the rate of $12.36 per share. Total worth of this trade was $7,688. Total number of shares owned as of Jan 03 were 11,207
Posted by on Thursday January 07 2021, 6:18 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

Featured Press Releases

Log in